The present study was carried out to assess whether endogenous angiotensin II (Ang II) supports sympathetically mediated cardiovascular response to stress in conscious unrestrained rats, using experimental models in which the renin-angiotensin-system was reduced or blocked. Footshock-stress increased mean arterial pressure (MAP) and heart rate (HR). Inhibition of angiotensin-converting enzyme with captopril or blockade of AT 1 angiotensin receptor with losartan, attenuated vasopressor responses to footshocks, while heart rate response was not altered. Bilateral nephrectomy suppressed vasopressor response as well the elevation of
Introduction
It is well known that a relationship exists between the renin-angiotensin system (RAS) and the stress response. Renin secretion and consequently circulating levels of angiotensin II (Ang II) are increased in a number of stress paradigms. 1, 2 Several studies performed both in animal models and in humans suggest that Ang II is involved in the regulation of sympathetic nervous system and could have a role in stress-induced cardiovascular responses, at least in part by supporting sympathetic outflow. 3 Studies of the effect of inhibition of the RAS on the cardiovascular responses to sympathetic activation support this notion. Various inhibitors of the RAS cascade have been used to investigate the relationship between these two vasopressor systems. 4 A commonly used preparation has been the pithed rat. Indeed, it was shown that experiments, which acutely inhibit RAS, were effective to impair the cardiovascular responses to sympathetic stimulation in pithed rats. [5] [6] [7] [8] These results were interpreted by some in terms of the blockade of the vascularly generated Ang II, however by others as the circulating RAS. In another experimental model such as lower body negative pressure in anesthetised cats, a man-plasma noradrenaline and adrenaline induced by footshocks, and reduced heart rate response. Cardiovascular response to stress in nephrectomised rats was restored by exogenous administration of a subpressor dose of Ang II. Our results demonstrate that in conscious rats cardiovascular response to footshocks is dependent on an active renin-angiotensin system and they indicate that endogenous Ang II supports the sympathetically mediated vasopressor response to footshocks. oeuver that reduces central blood volume and arterial pressure, which in turn activates sympathetic reflexes, it was shown that inhibition of the angiotensin-converting enzyme or blockade of Ang II receptor augmented the hypotensive response to lower body negative pressure, suggesting that Ang II increases the activity of the sympathetic nervous system. 9 Considerable evidence supports the proposal that endogenous Ang II facilitates sympathetic transmission, however most of the experiments were performed in isolated organs, in pithed or anesthetised rats, models in which the basal blood pressure in low or with a stimulated RAS, or with the use of pharmacological doses of exogenous Ang II; furthermore direct sympathetic nerves were stimulated electrically. 10, 11 In fact, few authors have examined the interaction between Ang II and the sympathetic nervous system under conditions of normal Ang II concentration and of an intact central control of sympathetic activity. Hence the question of whether endogenous Ang II in conscious animals is able to influence the cardiovascular response to a stressor stimulus is still a matter of debate.
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Therefore, in this study we investigate the interplay between the RAS and sympathetic nervous system (SNS) stimulation, in a model of acute stress applied to conscious unrestrained rats. Our aim was to determine whether the presence of an intact RAS S85 is a determinant for the sympathetic response to footshocks. In order to suppress the RAS, rats were subjected to bilateral nephrectomy, inhibition of converting enzyme activity with captopril or to blockade of AT 1 angiotensin receptor with losartan. It was reasoned that if Ang II supports sympathetically immediate cardiovascular response in conscious unrestrained rats, interference with the RAS at several levels should decrease sympathetic activity and consequently cardiovascular response to footshocks.
Materials and methods
Male Sprague-Dawley rats (160-190 g) were obtained from an established colony at the School of Pharmacy, Central University of Venezuela. The rats were provided with standard rat food and water ad libitum and were housed under controlled conditions of temperature and photoperiod (light on from 06.00 to 18.00).
Quantification of cardiovascular responses to footshocks
Systolic and diastolic pressure and heart rate were recorded daily using a tail-cuff digital plethysmograph (LE 5000, LETICA Scientific Instruments, Barcelona, Spain) as described previously. 12, 13 After drug treatment, the animals were transferred to a Plexiglas chamber with a copper rod floor where they received mild footshocks (2.0 Hz, 100 V, 5 ms, for 5 min) delivered by a Grass stimulator (Model S48). The rats were placed into the heating oven and after 10 min of heating, footshock-stimulation was performed inside the oven for a period of 5 min. Immediately after this procedure, measurements of the cardiovascular responses were taken. Basal mean arterial pressure (MAP) and heart rate (HR) were determined before each treatment and 5 min before the start of the experiment with footshocks. The MAP and HR determined immediately before footshocks were considered as basal. In separate groups of animals the following treatments were given: saline, captopril (10 mg/kg, i.p.) or losartan (3 or 10 mg/kg, s.c.), 1 h prior to footshocks.
Bilateral nephrectomy
Bilateral nephrectomy was performed, 18-24 h before footshocks, under pentobarbital anaesthesia (40 mg/kg, i.p.). To prevent accumulation of body fluid volume, the nephrectomised rats were deprived of water during the experiment. In order to revert the effect of nephrectomy on the cardiovascular response to footshocks, a group of nephrectomised rats were treated with a subpressor dose of synthetic Ang II (12.5 g/kg, s.c.) immediately before starting footshock-stress. To assess the effect of nephrectomy-induced hyperkalaemia, a
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Plasma catecholamines measurement
Rats were randomly distributed into two experimental groups sham or nephrectomised. Half of the rats were subjected to footshocks. Samples of arterial blood (abdominal aorta) were collected under pentobarbital anesthesia (80 mg/kg). Blood samples were collected (4 ml) into tubes containing 5% EDTA and 0.2 ml of sodium methabisulphite (5%) and centrifuged immediately at 15 000 rpm for 10 min at 5°C to separate the plasma. Plasma samples were stored at −70°C and analysed within 1 week. Plasma concentration of noradrenaline (NA) and adrenaline (A) were assayed using reversephase high-performance liquid chromatography (HPLC) with electrochemical detection after partial purification by adsorption on alumina.
14,15 Catechol concentration in each sample were corrected for recovery of the internal standard, dihydroxybenzylamine. The limits of detection for NA and A were 2-4 pg per volume injected.
Statistics
All data are expressed as HR (bites per minute) and MAP (mm Hg) calculated from the sum of diastolic blood pressure and one-third the pulse pressure, and expressed as the means ± s.e.m. Statistical differences between groups were evaluated by one-way analysis of variance (ANOVA) and pair wise comparisons according to the Bonferroni method. A value of P Ͻ 0.05 was considered significant.
Results
Alpha-adrenoreceptor blockade with phentolamine significantly antagonised the pressor response to footshocks (2 Hz). Increase in MAP, mm Hg: controlsaline: 21.2 ± 1.4 and phentolamine 5.05 ± 0.59 (n = 10). Heart rate response was not altered by phentolamine (not shown).
As shown in Figure 1 , footshock-stress induced an increase in tail-cuff MAP and HR. Administration of captopril (10 mg/kg, i.p.) or losartan (3 or 10 mg/kg, s.c.) significantly blocked the pressor response to footshocks (2 Hz) compared with the response observed in controls. Heart rate response was not altered by the treatment (not shown).
Bilateral nephrectomy inhibited the vasopressor response to footshocks compared with sham-operated controls (Figure 1 ). In addition, there was a significant decrease in the HR response to footshocks in bilaterally nephectomised rats (not shown). Table 1 , footshocks significantly increased plasma concentration Figure 1 Pressor response to footshocks in rats treated with captopril or losartan subjected to bilateral nephrectomy. Results are expressed as mean arterial pressure (MAP) in mm Hg and they represent the mean ± s.e.m. Saline n = 20-27; sham n = 7; losartan n = 15 and 27; captopril n = 8; nephrex n = 7. *P Ͻ 0.01, **P Ͻ 0.001 compared with control. of NA and A. These increases in plasma catecholamines induced by footshocks were blunted by bilateral nephrectomy. When bilaterally nephrectomised rats were injected with a subpressor response of synthetic Ang II (12.5 g/kg), immediately before footshocks, the lack of response of haemodynamic parameters to footshocks were reverted (Figure 2) . Serum potassium levels rise significantly after nephrectomy and this rise was prevented by kayexalate. Potassium serum levels in mEq/L = sham: 3.29 ± 0.1 (n = 9); nephrex: 6.64 ± 0.3 (n = 8) and nephrex+ky: 4.7 ± 0.44 (n = 4). Reduction of nephrectomy-induced serum potassium levels accumulation did not reverted the lack of cardiovascular response to footshock-stress (Figure 2 ).
Discussion
Acute stress induced by footshocks causes sympathoadrenal activation with increases in arterial Figure 2 Effect of bilateral nephrectomy on the pressor response to footshocks in rats. Effect of exogenous Ang II administration or treatment with kayexelate. Results are expressed as mean arterial pressure (MAP) in mm Hg, and they are mean ± s.e.m. Sham n = 11; nephrex n = 13; nephrex + Ang II n = 7; nephrex + Ky n = 6. ***P Ͻ 0.0001 compared with control. pressure and heart rate. 16 Several models of stress are known to increase renin secretion and consequently circulating levels of Ang II.
1,2 Thus Ang II might contribute to the vasopressor response to footshocks in a manner other than by inducing a contraction of vascular muscle cells. Ang II could conceivably enhance the involvement of other pressor system such as the sympathetic nervous system (SNS). Ang II might interact with the SNS in different ways. It modulates the SNS response to stimulation of cardiovascular reflex by central mechanism 17 and facilitates sympathetic transmission in several organs. 18, 19 Circulating Ang II can gain access to central nuclei implicated in cardiovascular regulation through areas devoid of the blood-brain barrier and in this manner mediate an increase in sympathetic nerve activity. 20 In the periphery, Ang II facilitates the release of noradrenaline from nerve endings. 21 Thus, inhibition of the angiotensinconverting enzyme (kininase II) to block the conversion of Ang I to Ang II and blockade of angiotensin receptor with losartan or removal of both kidneys to reduce plasma renin activity (PRA) to a very low level, 6 should reduce the facilitatory action of endogenous Ang II during sympathoadrenal stimulation.
In an attempt to demonstrate this hypothesis, we induced an enhancement of sympathetic activity with mild inescapable footshocks presented to conscious rats.
The present study extends previous reports, and demonstrated that acute blockade of the RAS cascade with captopril or losartan can cause inhibition of the vasopressor response to footshocks, suggesting that in conditions in which RAS is markedly elevated such as acute stress, 22 adrenergically mediated vasopressor response may be supported, or even intensified, by endogenous Ang II, ie facilitation of sympathetic activity, inasmuch as this pressor response was almost completely abolished by the alpha-adrenergic blocker phentolamine (3 mg/kg, i.p.). Our study further demonstrates that endogenous Ang II modulates vasopressor response to stress via the AT 1 receptors. The interaction between Ang II and SNS occurs most likely on sympathetic activity resides at the prejunctional AT 1 receptors located at the sympathetic nerve terminals, where the facilitatory input of endogenous Ang II would be blunted by blockade with losartan. 13 Thus, it is plausible to conceive that the inhibitory action of losartan on the Ang II-induced facilitation of noradrenergic transmission during sympathoadrenal stimulation induced by footshocks could be attributed to the blocking of any interaction between Ang II and its AT 1 receptors.
Evidence supporting a role for circulating renin of renal origin or the intrarenal RAS in the sympathetic response to footshocks comes from our present observation that sympathetic responses to footshocks, manifested as increase in MAP, HR and plasma catecholamines were abolished after removal of both kidneys, an effect that was unJournal of Human Hypertension related to potassium serum levels. Thus, removal of both kidneys reduces the PRA to a very low level and the consequent lowering of Ang II formation may account for the blockade of the sympathetic response to footshocks. It would be anticipated that if reductions in plasma Ang II levels induced by nephrectomy were responsible for sympathetic inhibition, administration of exogenous Ang II, in a subpressor dose, should restore responses to sympathetic stimulation after stress. In effect, we show that intraperitoneal injection of a subpressor dose of synthetic Ang II fully restored the inhibited sympathetic responses to footshocks in bilaterally nephrectomised rats.
The absence of vasopressor response to footshocks in losartan or captoptil treated rats, together with lack of response in bilaterally nephrectomised rats, suggest that the presence of endogenous Ang II appears to be necessary for the full expression of sympathetic response to footshock-stress. We propose that in conscious rats, Ang II plays a critical role in the sympathetic response to stress, at least in part by supporting sympathetic outflow.
